Provided by Tiger Trade Technology Pte. Ltd.

Achieve Life Sciences, Inc.

7.96
-0.0300-0.38%
Volume:507.77K
Turnover:4.01M
Market Cap:817.17M
PE:-4.80
High:8.12
Open:7.98
Low:7.68
Close:7.99
52wk High:8.61
52wk Low:2.62
Shares:102.66M
Float Shares:74.67M
Volume Ratio:0.45
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6600
EPS(LYR):-1.2535
ROE:-844.99%
ROA:-29.21%
PB:-55.68
PE(LYR):-6.35

Loading ...

Company Profile

Company Name:
Achieve Life Sciences, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
28
Office Location:
22722 29th Dr. SE,Suite 100,Bothell,Washington,United States
Zip Code:
98021
Fax:
- -
Introduction:
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Directors

Name
Position
Andrew D. Goldberg
Chief Executive Officer and Director and President
Lucian Iancovici
Chairman of the Board and Director
Aaron Royston
Director
Chris Martin
Director
Jeffrey Farrow
Director
Nancy R. Phelan
Director
Reid Waldman
Director
Richard Stewart
Director
Thomas Sellig
Director

Shareholders

Name
Position
Andrew D. Goldberg
Chief Executive Officer and Director and President
Mark Oki
Chief Financial Officer
Craig Donnelly
Chief Operations Officer
Erik Atkisson
Chief Legal Officer
Mark Rubinstein
Chief Medical Officer